ProfileOfResearchers

TITLE: Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial
AUTHORS: Matthew A Powell; Virginia L Filiaci; Martee L Hensley; Helen Q Huang; Kathleen N Moore; Krishnansu S Tewari; Larry J Copeland; Angeles A Secord; David G Mutch; Alessandro Santin; David P Warshal; Nick M Spirtos; Paul A DiSilvestro; Olga B Ioffe; David Scott Miller ;
PUBLISHED: 2022, SOURCE: Journal of Clinical Oncology, VOLUME: 40, ISSUE: 9

INDEXED IN:

Scopus

IN MY:

ORCID

TITLE: Risk factors associated with 30-day postoperative complications following contemporary vulvectomies with inguinofemoral lymphadenectomies for gynecologic cancers Full Text
AUTHORS: Alexandra Spirtos; Salvatore Lococo; Matthew Carlson; Jayanthi Lea; David Scott Miller ; Jessica Lee;
PUBLISHED: 2022, SOURCE: Gynecologic Oncology, VOLUME: 164, ISSUE: 1

INDEXED IN:

CrossRef

IN MY:

ORCID

TITLE: 145 Characterization of adverse reactions in patients with advanced endometrial cancer (aec) receiving lenvatinib + pembrolizumab (Study 309/KEYNOTE-775)
AUTHORS: Colombo, N; Lorusso, D; AD Santin; YM Kim; AC Herráez; Yonemori, K; Fujiwara, K; Colomba, E; David Scott Miller ; Pignata, S; BJ Monk; EM Guerra; Kristeleit, R; Orlando, M; UA Sanli; Dutta, L; Orlowski, R; Ren, M; Makker, V;
PUBLISHED: 2021, SOURCE: Endometrial cancer

INDEXED IN:

CrossRef: 2

IN MY:

ORCID

TITLE: 726MO Outcomes by histology and prior therapy with lenvatinib plus pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer (Study 309/KEYNOTE-775)
AUTHORS: Colombo, N; Lorusso, D; Casado C Herráez; A.D Santin; Colomba, E; David Scott Miller ; Fujiwara, K; Pignata, S; Floquet, A; B.J Monk; Banerjee, S; R.T Penson; Kristeleit, R; Fabbro, M; Orlando, M; Mackay, H; Jensen, E; Dutta, L; Orlowski, R; Makker, V;
PUBLISHED: 2021, SOURCE: Annals of Oncology, VOLUME: 32

INDEXED IN:

CrossRef: 17

IN MY:

ORCID

TITLE: A multicenter, open-label, randomized, phase III study to compare the efficacy and safety of lenvatinib in combination with pembrolizumab versus treatment of physician's choice in patients with advanced endometrial cancer Full Text
AUTHORS: Vicky Makker; Nicoletta Colombo; Antonio Casado Herráez; Alessandro Santin; Emeline Colomba; David Scott Miller ; Keiichi Fujiwara; Sandro Pignata; Sally Baron-Hay; Isabelle Ray-Coquard; Ronnie Shapira-Frommer; Kimio Ushijima; Jun Sakata; Kan Yonemori; Yong Man Kim; Eva Guerra; Ulus Sanli; Mary McCormack; Jie Huang; Alan Smith; Stephen Keefe; Lea Dutta; Robert Orlowski; Domenica Lorusso; ...More
PUBLISHED: 2021, SOURCE: Gynecologic Oncology, VOLUME: 162

INDEXED IN:

CrossRef: 27

IN MY:

ORCID

TITLE: Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis Full Text
AUTHORS: Kimberly Levinson; Anna L Beavis; Christopher Purdy; Anne F Rositch; Akila Viswanathan; Aaron H Wolfson; Michael G Kelly; Krishnansu S Tewari; Leah McNally; Saketh R Guntupalli; Omar Ragab; Yi Chun Lee; David Scott Miller ; Warner K Huh; Kelly J Wilkinson; Nicola M Spirtos; Linda Van Le; Yovanni Casablanca; Laura L Holman; Steven E Waggoner; Amanda N Fader; ...More
PUBLISHED: 2021, SOURCE: Gynecologic Oncology, VOLUME: 162, ISSUE: 3

INDEXED IN:

Scopus

IN MY:

ORCID

TITLE: Corrigendum to “Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis” [Gynecologic Oncology 162 (2021) 532–538](S0090825821005114)(10.1016/j.ygyno.2021.06.017) Full Text
AUTHORS: Kimberly Levinson; Anna L Beavis; Christopher Purdy; Anne F Rositch; Akila Viswanathan; Aaron H Wolfson; Michael G Kelly; Krishnansu S Tewari; Leah McNally; Saketh R Guntupalli; Omar Ragab; Yi Chun Lee; David Scott Miller ; Warner K Huh; Kelly J Wilkinson; Nicola M Spirtos; Linda Van Le; Yovanni Casablanca; Laura L Holman; Steven E Waggoner; Amanda N Fader; ...More
PUBLISHED: 2021, SOURCE: Gynecologic Oncology, VOLUME: 163, ISSUE: 3

INDEXED IN:

Scopus

IN MY:

ORCID

TITLE: Delayed time to surgery with hormonal treatment does not adversely impact outcomes in women with low-grade endometrioid endometrial cancer Full Text
AUTHORS: Sydney Oesch; Eugenia Kakadiaris; David Scott Miller ; Matthew Carlson; Jessica Lee; Salvatore Lococo; Jayanthi Lea;
PUBLISHED: 2021, SOURCE: Gynecologic Oncology, VOLUME: 162

INDEXED IN:

CrossRef

IN MY:

ORCID

TITLE: Health-related quality of life (HRQoL) in advanced endometrial cancer (aEC) patients (pts) treated with lenvatinib plus pembrolizumab or treatment of physician’s choice (TPC).
AUTHORS: Domenica Lorusso; Nicoletta Colombo; Antonio Casado Herraez; Alessandro Santin; Emeline Colomba; David Scott Miller ; Keiichi Fujiwara; Sandro Pignata; Sally E Baron-Hay; Isabelle Laure Ray-Coquard; Ronnie Shapira-Frommer; Yong Man Kim; Mary McCormack; Steven Bird; Vimalanand S Prabhu; Allison Martin Nguyen; Qi Zhao; Lea Dutta; Vicky Makker;
PUBLISHED: 2021, SOURCE: Journal of Clinical Oncology, VOLUME: 39, ISSUE: 15_suppl

INDEXED IN:

CrossRef: 9

IN MY:

ORCID